Loading Events

« All Events

April 2021

Provider Support Initiative Webinar Series

April 27 @ 12:00 pm - 1:00 pm PDT
|Recurring Event (See all)

An event every month that begins at 12:00 pm on day Fourth of the month, repeating until December 15, 2021

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…

May 2021

Provider Support Initiative Webinar Series

May 25 @ 12:00 pm - 1:00 pm PDT
|Recurring Event (See all)

An event every month that begins at 12:00 pm on day Fourth of the month, repeating until December 15, 2021

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…

June 2021

Provider Support Initiative Webinar Series

June 22 @ 12:00 pm - 1:00 pm PDT
|Recurring Event (See all)

An event every month that begins at 12:00 pm on day Fourth of the month, repeating until December 15, 2021

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…

July 2021

Provider Support Initiative Webinar Series

July 27 @ 12:00 pm - 1:00 pm PDT
|Recurring Event (See all)

An event every month that begins at 12:00 pm on day Fourth of the month, repeating until December 15, 2021

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…

August 2021

Provider Support Initiative Webinar Series

August 24 @ 12:00 pm - 1:00 pm PDT
|Recurring Event (See all)

An event every month that begins at 12:00 pm on day Fourth of the month, repeating until December 15, 2021

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…

September 2021

Provider Support Initiative Webinar Series

September 28 @ 12:00 pm - 1:00 pm PDT
|Recurring Event (See all)

An event every month that begins at 12:00 pm on day Fourth of the month, repeating until December 15, 2021

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…

October 2021

Provider Support Initiative Webinar Series

October 26 @ 12:00 pm - 1:00 pm PDT
|Recurring Event (See all)

An event every month that begins at 12:00 pm on day Fourth of the month, repeating until December 15, 2021

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…

November 2021

Provider Support Initiative Webinar Series

November 23 @ 12:00 pm - 1:00 pm PST
|Recurring Event (See all)

An event every month that begins at 12:00 pm on day Fourth of the month, repeating until December 15, 2021

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…